Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) EBIT Margin (2019 - 2025)

Korro Bio (KRRO) has disclosed EBIT Margin for 5 consecutive years, with 1764.86% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBIT Margin changed N/A year-over-year to 1764.86%, compared with a TTM value of 1282.04% through Sep 2025, changed N/A, and an annual FY2024 reading of 4047.12%, changed N/A over the prior year.
  • EBIT Margin was 1764.86% for Q3 2025 at Korro Bio, up from 1863.15% in the prior quarter.
  • Across five years, EBIT Margin topped out at 7072.54% in Q1 2023 and bottomed at 1863.15% in Q2 2025.
  • Average EBIT Margin over 4 years is 118.41%, with a median of 981.18% recorded in 2025.
  • Peak annual rise in EBIT Margin hit -11291bps in 2021, while the deepest fall reached -35644bps in 2021.
  • Year by year, EBIT Margin stood at 185.65% in 2021, then surged by 3910bps to 7072.54% in 2023, then plummeted by -114bps to 1014.53% in 2024, then plummeted by -74bps to 1764.86% in 2025.
  • Business Quant data shows EBIT Margin for KRRO at 1764.86% in Q3 2025, 1863.15% in Q2 2025, and 981.18% in Q1 2025.